CID 16130432

Iqp0410 & isis 5320

Structural Information

Molecular Formula
C80H100N28O44P8S8
SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=S)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=S)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=S)(O)O[C@H]5C[C@@H](O[C@@H]5COP(=S)(O)O[C@H]6C[C@@H](O[C@@H]6COP(=S)(O)O[C@H]7C[C@@H](O[C@@H]7COP(=S)(O)O[C@H]8C[C@@H](O[C@@H]8COP(=S)(O)O[C@H]9C[C@@H](O[C@@H]9CO[P+](=O)[S-])N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)O
InChI
InChI=1S/C80H100N28O44P8S8/c1-29-13-101(77(118)97-65(29)110)49-5-33(109)41(138-49)18-131-154(123,162)147-35-7-51(103-15-31(3)67(112)99-79(103)120)140-43(35)20-133-157(126,165)149-37-9-53(105-25-85-57-61(105)89-73(81)93-69(57)114)143-46(37)22-135-159(128,167)151-39-11-55(107-27-87-59-63(107)91-75(83)95-71(59)116)145-48(39)24-137-160(129,168)152-40-12-56(108-28-88-60-64(108)92-76(84)96-72(60)117)144-47(40)23-136-158(127,166)150-38-10-54(106-26-86-58-62(106)90-74(82)94-70(58)115)142-45(38)21-134-156(125,164)148-36-8-52(104-16-32(4)68(113)100-80(104)121)141-44(36)19-132-155(124,163)146-34-6-50(139-42(34)17-130-153(122)161)102-14-30(2)66(111)98-78(102)119/h13-16,25-28,33-56,109H,5-12,17-24H2,1-4H3,(H,123,162)(H,124,163)(H,125,164)(H,126,165)(H,127,166)(H,128,167)(H,129,168)(H,97,110,118)(H,98,111,119)(H,99,112,120)(H,100,113,121)(H3,81,89,93,114)(H3,82,90,94,115)(H3,83,91,95,116)(H3,84,92,96,117)/t33-,34-,35-,36-,37-,38-,39-,40-,41+,42+,43+,44+,45+,46+,47+,48+,49+,50+,51+,52+,53+,54+,55+,56+,154?,155?,156?,157?,158?,159?,160?/m0/s1
InChIKey
CJTXOWFJPLCGQO-SYZDRKSMSA-N
Compound name
[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[hydroxy-[[(2R,3S,5R)-3-[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxo-sulfidophosphanium
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2660.2114 Da
Monoisotopic Mass

-3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2661.2187 279.9
[M+Na]+ 2683.2006 288.5
[M-H]- 2659.2041 281.8
[M+NH4]+ 2678.2452 283.5
[M+K]+ 2699.1746 284.5
[M+H-H2O]+ 2643.2087 281.4
[M+HCOO]- 2705.2096 283.8
[M+CH3COO]- 2719.2253 284.5
[M+Na-2H]- 2681.1861 289.2
[M]+ 2660.2109 290.1
[M]- 2660.2119 290.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.